Young Matthew M, Stevens Adrienne, Galipeau James, Pirie Tyler, Garritty Chantelle, Singh Kavita, Yazdi Fatemeh, Golfam Mohammed, Pratt Misty, Turner Lucy, Porath-Waller Amy, Arratoon Cheryl, Haley Nancy, Leslie Karen, Reardon Rhoda, Sproule Beth, Grimshaw Jeremy, Moher David
Canadian Centre on Substance Abuse (CCSA), 75 Albert Street, Ottawa, Ontario K1P 5E7, Canada.
Syst Rev. 2014 May 24;3:50. doi: 10.1186/2046-4053-3-50.
The purpose of this systematic review is to assess the effectiveness of brief interventions (BIs) as part of the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model for reducing the nonmedical use of psychoactive substances.
Bibliographic databases (including MEDLINE, Embase, The Cochrane Library, CINAHL, and PsycINFO to April 2012) and gray literature sources were searched. We included randomized controlled trials that opportunistically screened adolescents or adults and then provided a one-to-one, verbal BI to those at risk of substance-use harm. Of interest was the nonmedical use of psychoactive substances (for example, drugs prohibited by international law), excluding alcohol, nicotine, and caffeine. Interventions comprised four or fewer sessions and were compared with no/delayed intervention or provision of information only. Studies were assessed for bias using the Cochrane risk of bias tool. Results were synthesized narratively. Evidence was interpreted according to the GRADE framework.
We identified 8,836 records. Of these, five studies met our inclusion criteria. Two studies compared BI with no BI, and three studies compared BI with information only. Studies varied in characteristics such as substances targeted, screening procedures, and BI administered. Outcomes were mostly reported by a single study, leading to limited or uncertain confidence in effect estimates.
Insufficient evidence exists as to whether BIs, as part of SBIRT, are effective or ineffective for reducing the use of, or harms associated with nonmedical use of, psychoactive substances when these interventions are administered to nontreatment-seeking, screen-detected populations. Updating this review with emerging evidence will be important.
CRD42012002414.
本系统评价旨在评估作为筛查、简短干预及转介治疗(SBIRT)模式一部分的简短干预(BI)对减少精神活性物质非医疗使用的有效性。
检索了文献数据库(包括截至2012年4月的MEDLINE、Embase、Cochrane图书馆、CINAHL和PsycINFO)及灰色文献来源。我们纳入了机会性筛查青少年或成年人,然后对有物质使用危害风险者提供一对一、口头BI的随机对照试验。关注的是精神活性物质的非医疗使用(例如国际法禁止的药物),不包括酒精、尼古丁和咖啡因。干预包括四个或更少疗程,并与无干预/延迟干预或仅提供信息进行比较。使用Cochrane偏倚风险工具评估研究的偏倚。结果进行叙述性综合。证据根据GRADE框架进行解释。
我们识别出8836条记录。其中,五项研究符合我们的纳入标准。两项研究比较了BI与无BI,三项研究比较了BI与仅提供信息。研究在目标物质、筛查程序和实施的BI等特征方面存在差异。结果大多由单个研究报告,导致对效应估计的信心有限或不确定。
对于将BI作为SBIRT的一部分应用于未寻求治疗、筛查发现的人群时,在减少精神活性物质的使用或与非医疗使用相关的危害方面是否有效,证据不足。用新出现的证据更新本评价将很重要。
CRD42012002414。